Medical Device and Diagnostic Industry (MD+DI)Opinion

Dexcom Learns a Lesson in Transparency

Customers have known for months that the Dexcom G7 continuous glucose monitoring sensor had problems. Now, the company is ...
The Motley Fool

Why Eli Lilly and Novo Nordisk are even in the picture

At first blush, it might seem odd to think that Lilly and Novo Nordisk had anything to do with DexCom's sharp decline. So why are the two drugmakers even in the picture? DexCom CEO Kevin Sayer said on ...
Benzinga.com

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...
Medscape

Dexcom Issues Recall for G7, ONE+ Apps for Software Issues

Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of unexpected sensor failures. This recall ...